UCB Group : Keppra® Patent | UCB
UCB's Global Corporate Website

This section is intended for media and financial analysts

UCB Group : Keppra® Patent

pdf english

22nd March, 2004 - In line with UCB's previous declaration of vigorous defense of its intellectual property rights for Keppra®, UCB has sued in the U.S.A. the two companies that had filed an ANDA for Keppra®

Stay up-to-date on the latest news and information from UCB

Subscribe